Eris Lifesciences stated that its consolidated net profit increased 12 per cent to Rs 101 crore for the third quarter ended December 2021.
The company stated that the revenue stood at Rs 332 crore in the third quarter of the current fiscal as against Rs 310 crore in the year-ago period, Eris Lifesciences said.
''Our focus on building leadership brands in fast-growing therapies coupled with several patent expiration opportunities will enable us to sustain our growth trajectory,'' stated Eris Lifesciences Chairman & Managing Director Amit Bakshi.
(With inputs from PTI)
Brazilian Model Larissa Reacts To Rahul Gandhi’s Claim Of Her Voting 22 Times In Haryana; Calls It 'Unbelievable'- Video
Kyunki Saas Bhi Kabhi Bahu Thi 2 Written Update, November 5: Mitali Gets Possessed, Attacks Angad
Bihar Assembly Elections 2025: Voting For First Phase Of NDA Vs Mahagathbandhan High-Stakes Battle To Begin Soon
'Rahul Gandhi Pagal Hai': Assam CM Himanta Biswa Sarma Demands Congress MP Be Officially Declared 'Mad' Over Indian Army Remark - VIDEO
